Replies to post #66068 on SOHM Inc (SHMN)

[hardlesson]

I will not stop posting positives about this company, as long as Aguilar delivers.

All you posted was pre-Aguilar.

The company is much different now, and is poised to capitalize and commercialize.

I noticed you haven't weighed in on all the new hires very much, and heavy involvement of other companies.

Aguilar, Gallegos, Bhatt, Zarling, University of AZ, Coastar, Stanford Medicine, Kawamura, Carlsbad, FDA, Gummies, Amazon, Joseph Jackson, Sowmya, Levitiracetam, Patent Attorney Furman, etc, etc.

This is not the old SOHM, if you don't have trust, that's on you.

I do agree with you about not roping in new eyes, all should be cautious in the OTC especially.

I understand the past history was largely undelivered.

Lunch and Learn in a week with Sohm, Coastar, Hygia, at LaJolla Institute.

I'm staying positive, but I respect your opinion greatly.

[Myth]

TWEET


SOHM, Inc.
@sohminc
We are pleased to share that the company is successfully negotiating with a diverse range of companies, from the top 10 pharmaceutical giants to small private firms, regarding the ABBIE kits. Detailed information will be provided once we finalize the contracts, sales, delivery methods, and purposes, which we anticipate will occur in the coming weeks.

The interest and attention our breakthrough gene editing technology has garnered, particularly in its application for drug development, is truly gratifying. We continue to explore new opportunities and are organizing several lunch-and-learn sessions throughout the fourth quarter to prepare for revenue growth in 2025.